Group Opposes Caremark, Express Scripts Union

Law360, New York (January 30, 2007, 12:00 AM EST) -- A merger between pharmaceutical benefit top guns Caremark Rx Inc. and Express Scripts Inc. would further stifle an already concentrated market and make it even harder for smaller companies to break through, an antitrust think tank warned the Federal Trade Commission on Monday.

Based on its independent review, the American Antitrust Institute urged the FTC to consider six points, which reveal the problems that could emerge if Express Scripts takes over Caremark.

“The AAI believes that the proposed acquisition poses the threat of significant anti-competitive harm...
To view the full article, register now.